Joseph Bastin
Optometrist · Hopkinsville, KYNPI 1063838274
Payments from drug & device makers
Across 50 payments — averaging $28.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$408
- Bausch & Lomb Americas Inc.$187
- Coopervision Inc.$160
- Sight Sciences, Inc.$125
- Shire North American Group Inc$122
- AbbVie$116
- plus $307 from 5 others
What the payments were for
- Food & beverage$1,425100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 24 | $408 |
| Bausch & Lomb Americas Inc. | 2 | $187 |
| Coopervision Inc. | 10 | $160 |
| Sight Sciences, Inc. | 1 | $125 |
| Shire North American Group Inc | 1 | $122 |
| AbbVie | 1 | $116 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $87 |
| LKC Technologies, Inc. | 1 | $67 |
| Johnson & Johnson Vision Care, Inc. | 4 | $60 |
| ABB Con-cise Optical Group LLC | 3 | $55 |
| Integra Lifesciences Corporation | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE$132
- OMNI(R) SURGICAL SYSTEM (US)$125
- XIIDRA$122
- VUITY$116
How this compares
$1,425 in reported general payments places this provider in the 65th percentile of 712 optometrist providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 126 | $1,343 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 75 | $815 |
| Timolol Maleate | 39 | $645 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 32 | $521 |
| Prednisolone Acetate | 12 | $390 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 17 | $312 |
| Brimonidine Tartrate | 15 | $187 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Hopkinsville
- Paul KarpeckiLexington$3.7M
- Bilal AhmadLexington$150K
- Clay MattsonNicholasville$93K
- Ben LeonardCalvert City$75K
- Lee PeplinskiLouisville$74K
- Austin LifferthLouisville$72K
- Christopher KucLexington$53K
- Kristine Kerestan GarbigWilder$51K
- Renee ReederPikeville$27K
- Karoline MunsonFrankfort$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.